149 related articles for article (PubMed ID: 24723653)
21. Alterations of the p53 and PIK3CA/AKT/mTOR pathways in angiosarcomas: a pattern distinct from other sarcomas with complex genomics.
Italiano A; Chen CL; Thomas R; Breen M; Bonnet F; Sevenet N; Longy M; Maki RG; Coindre JM; Antonescu CR
Cancer; 2012 Dec; 118(23):5878-87. PubMed ID: 22648906
[TBL] [Abstract][Full Text] [Related]
22. The synergistic inhibition of breast cancer proliferation by combined treatment with 4EGI-1 and MK2206.
Wang H; Huang F; Wang J; Wang P; Lv W; Hong L; Li S; Zhou J
Cell Cycle; 2015; 14(2):232-42. PubMed ID: 25607647
[TBL] [Abstract][Full Text] [Related]
23. Deconstructing mTOR complexes in regulation of Glioblastoma Multiforme and its stem cells.
Jhanwar-Uniyal M; Jeevan D; Neil J; Shannon C; Albert L; Murali R
Adv Biol Regul; 2013 May; 53(2):202-10. PubMed ID: 23231881
[TBL] [Abstract][Full Text] [Related]
24. Increased milk protein synthesis in response to exogenous growth hormone is associated with changes in mechanistic (mammalian) target of rapamycin (mTOR)C1-dependent and independent cell signaling.
Sciascia Q; Pacheco D; McCoard SA
J Dairy Sci; 2013 Apr; 96(4):2327-2338. PubMed ID: 23462168
[TBL] [Abstract][Full Text] [Related]
25. Micro(RNA) managing by mTORC1.
Jewell JL; Flores F; Guan KL
Mol Cell; 2015 Feb; 57(4):575-576. PubMed ID: 25699705
[TBL] [Abstract][Full Text] [Related]
26. The role of IL-11 in immunity and cancer.
Xu DH; Zhu Z; Wakefield MR; Xiao H; Bai Q; Fang Y
Cancer Lett; 2016 Apr; 373(2):156-63. PubMed ID: 26826523
[TBL] [Abstract][Full Text] [Related]
27. [mTOR, the mammalian target of rapamycin].
Julien LA; Roux PP
Med Sci (Paris); 2010 Dec; 26(12):1056-60. PubMed ID: 21187044
[TBL] [Abstract][Full Text] [Related]
28. PI3King the lock: targeting the PI3K/Akt/mTOR pathway as a novel therapeutic strategy in neuroblastoma.
King D; Yeomanson D; Bryant HE
J Pediatr Hematol Oncol; 2015 May; 37(4):245-51. PubMed ID: 25811750
[TBL] [Abstract][Full Text] [Related]
29. PI3K-p110-alpha-subtype signalling mediates survival, proliferation and neurogenesis of cortical progenitor cells via activation of mTORC2.
Wahane SD; Hellbach N; Prentzell MT; Weise SC; Vezzali R; Kreutz C; Timmer J; Krieglstein K; Thedieck K; Vogel T
J Neurochem; 2014 Jul; 130(2):255-67. PubMed ID: 24645666
[TBL] [Abstract][Full Text] [Related]
30. Rapamycin ameliorates inflammation and fibrosis in the early phase of cirrhotic portal hypertension in rats through inhibition of mTORC1 but not mTORC2.
Wang W; Yan J; Wang H; Shi M; Zhang M; Yang W; Peng C; Li H
PLoS One; 2014; 9(1):e83908. PubMed ID: 24404143
[TBL] [Abstract][Full Text] [Related]
31. ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats.
Hu LY; Sun ZG; Wen YM; Cheng GZ; Wang SL; Zhao HB; Zhang XR
Neuroscience; 2010 Sep; 169(3):1046-62. PubMed ID: 20678995
[TBL] [Abstract][Full Text] [Related]
32. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.
Calvisi DF; Wang C; Ho C; Ladu S; Lee SA; Mattu S; Destefanis G; Delogu S; Zimmermann A; Ericsson J; Brozzetti S; Staniscia T; Chen X; Dombrowski F; Evert M
Gastroenterology; 2011 Mar; 140(3):1071-83. PubMed ID: 21147110
[TBL] [Abstract][Full Text] [Related]
33. Interplay between FOXO, TOR, and Akt.
Hay N
Biochim Biophys Acta; 2011 Nov; 1813(11):1965-70. PubMed ID: 21440577
[TBL] [Abstract][Full Text] [Related]
34. Autoregulation of the mechanistic target of rapamycin (mTOR) complex 2 integrity is controlled by an ATP-dependent mechanism.
Chen CH; Kiyan V; Zhylkibayev AA; Kazyken D; Bulgakova O; Page KE; Bersimbaev RI; Spooner E; Sarbassov DD
J Biol Chem; 2013 Sep; 288(38):27019-27030. PubMed ID: 23928304
[TBL] [Abstract][Full Text] [Related]
35. Rab1 GTPases as oncogenes.
Li Y; Wang HY; Zheng XF
Aging (Albany NY); 2015 Nov; 7(11):897-8. PubMed ID: 26590354
[No Abstract] [Full Text] [Related]
36. Receptor-recognized α₂-macroglobulin binds to cell surface-associated GRP78 and activates mTORC1 and mTORC2 signaling in prostate cancer cells.
Misra UK; Pizzo SV
PLoS One; 2012; 7(12):e51735. PubMed ID: 23272152
[TBL] [Abstract][Full Text] [Related]
37. AKT2 is essential to maintain podocyte viability and function during chronic kidney disease.
Canaud G; Bienaimé F; Viau A; Treins C; Baron W; Nguyen C; Burtin M; Berissi S; Giannakakis K; Muda AO; Zschiedrich S; Huber TB; Friedlander G; Legendre C; Pontoglio M; Pende M; Terzi F
Nat Med; 2013 Oct; 19(10):1288-96. PubMed ID: 24056770
[TBL] [Abstract][Full Text] [Related]
38. TOR signaling in mammals.
Carrera AC
J Cell Sci; 2004 Sep; 117(Pt 20):4615-6. PubMed ID: 15371520
[No Abstract] [Full Text] [Related]
39. Role of the Akt/mTOR signaling pathway in human papillomavirus-associated nasal and sinonasal inverted papilloma.
Liu Y; Duan L; Tian J; Song D; Zhang M; Zhao S; Yin Z; Xiang X; Li X
Acta Biochim Biophys Sin (Shanghai); 2017 Dec; 49(12):1067-1074. PubMed ID: 29040365
[TBL] [Abstract][Full Text] [Related]
40. Rapamycin prevents cadmium-induced neuronal cell death via targeting both mTORC1 and mTORC2 pathways.
Xu C; Liu C; Liu L; Zhang R; Zhang H; Chen S; Luo Y; Chen L; Huang S
Neuropharmacology; 2015 Oct; 97():35-45. PubMed ID: 26002629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
